Applied DNA Sciences Inc. has announced a 1-for-15 reverse stock split of its common stock, effective June 2, 2025. The company's shares will begin trading on a split-adjusted basis on Nasdaq under the symbol "APDN" from that date. This move is intended to help the company comply with Nasdaq's $1.00 minimum bid price requirement. The number of outstanding shares will reduce from approximately 7.8 million to about 519 thousand, with no change in the total authorized shares.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。